WaferGen Bio-systems, Inc.
DelistedCIK 1368993fmd_17QHW52V69ESQEKHPEZVVVN3DAManufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2016, 26 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|---|
| Total revenues | 2 | 1 | 1 | 1 | 6 | 7 |
| Cost of revenue | 1 | 1 | 0 | 1 | 3 | 3 |
| Net interest income | – | – | – | (3) | (1) | (0) |
| Gross profit | 1 | (1) | 0 | 1 | 3 | 4 |
| Research and development | 7 | 8 | 6 | 5 | 7 | 9 |
| Selling, general and administrative | 7 | 10 | 4 | 5 | 9 | 10 |
| Total operating expenses | 14 | 18 | 10 | 11 | 16 | 19 |
| Operating income | (13) | (19) | (10) | (10) | (12) | (15) |
| Interest expense | 0 | 3 | 2 | 3 | – | – |
| Interest and investment income | 0 | 0 | 0 | 0 | – | – |
| Other non-operating income (expense) | 0 | 6 | 2 | (6) | 2 | (0) |
| Income before taxes | (12) | (13) | (8) | (16) | (11) | (15) |
| Income tax expense | – | 0 | (0) | 0 | 0 | 0 |
| Net income from continuing operations | – | (13) | (8) | (16) | (11) | (15) |
| Net income | (12) | (13) | (8) | (16) | (11) | (15) |
| Net income to common shareholders | (13) | (23) | (9) | (18) | (11) | (20) |